Logo
Hyamira 32mg (1x2ml)

Hyamira 32mg (1x2ml)

Hyamira

Injectable dermal filler / skin booster
  • CE Marked medical device for intradermal / subcutaneous injection with hyaluronic acid.
  • Manufactured in accordance with European medical device quality and safety standards (including ISO Compliant production in APHARM laboratories).
  • Intended exclusively for professional use in compliant clinical environments and in accordance with local aesthetic medicine regulations.
Hyaluronic acid skin booster for hydration, turgidity and elasticity

Description

Hyamira 32mg (1x2ml) is a hyaluronic acid–based skin booster and dermal filler from Italian laboratory APHARM, designed to restore hydration, improve turgidity and enhance skin elasticity. Containing 32 mg of stabilised, viscoelastic hyaluronic acid in a 2 ml prefilled syringe, it is indicated for bio-revitalisation and anti-ageing treatments, particularly in patients seeking improved tone, firmness and overall skin quality. Injected into the superficial to mid dermis, Hyamira 32mg intensively rehydrates the skin, increases dermal volume and stimulates fibroblasts and vascularisation, contributing to endogenous collagen and hyaluronic acid production for a smoother, more youthful and radiant appearance.

Bnefits

  • Restores and maintains deep skin hydration by supplying a high concentration of hyaluronic acid.
  • Improves skin turgidity and elasticity, helping firm and tighten lax or tired skin.
  • Reduces visible signs of ageing such as fine lines and superficial wrinkles.
  • Enhances the skin’s natural protective barrier function and resilience.
  • Smooths the skin surface and helps refine overall texture and tone.
  • Provides an overall rejuvenating, radiant and more youthful appearance.
  • Bio-revitalising action that stimulates fibroblasts and angiogenesis, supporting endogenous collagen and hyaluronic acid production.
  • CE-marked medical device with biodegradable hyaluronic acid that is gradually resorbed by the body.

Indications

  • Dehydrated or dull skin requiring intensive rehydration.
  • Early and moderate signs of skin ageing, including fine lines and superficial wrinkles.
  • Loss of turgidity, firmness and elasticity of the skin.
  • Uneven skin tone and texture needing overall rejuvenation.
  • Biological revitalisation in adults, frequently recommended for patients around or over 40 years of age.
  • Improvement of skin quality on the face, neck and décolleté; some protocols extend use to hands or other visible areas, in line with practitioner judgement.

Composition

  • Hyaluronic acid 32 mg / 2 ml (16 mg/ml), non-animal origin, stabilised/viscoelastic
  • Physiological buffer solution (water for injection, sodium chloride and standard injectable excipients appropriate for a hyaluronic acid medical device)

Formulation

  • Sterile, apyrogenic, viscoelastic gel of stabilised hyaluronic acid for intradermal / superficial subcutaneous injection.
  • Non-animal origin hyaluronic acid with a concentration of 32 mg in a 2 ml prefilled syringe (approx. 16 mg/ml).
  • Biodegradable and biocompatible, gradually resorbed by physiological processes.
  • Designed as a skin booster / bio-revitalising filler, with hydrative and mild volumising properties rather than strong structural lifting.

Packaging

  • Box containing 1 prefilled glass syringe with 2 ml of Hyamira 32mg gel.
  • Typically supplied with disposable sterile needles appropriate for intradermal / superficial injections (exact size may vary by distributor).
  • Sterile blister packaging for syringe and needles within an outer carton with full labelling and instructions for use.
  • CE-marked medical device labelling, batch number and expiry date clearly indicated.

Usage

  • For professional use only: must be administered by trained healthcare professionals or aesthetic practitioners with appropriate qualifications in injectable treatments.
  • Cleanse and disinfect the treatment area thoroughly; apply topical anaesthetic according to clinic protocol if required.
  • Inject Hyamira 32mg into the superficial to mid dermis using micro-depot, linear threading, nappage or mesotherapy-style techniques according to the area treated and desired effect.
  • Typical treatment areas include face, neck and décolleté; some practitioners may treat hands or other indicated areas, following safe injection guidelines.
  • A treatment course commonly consists of several sessions spaced a few weeks apart (for example every 2–4 weeks), followed by maintenance sessions as needed, according to patient age, skin condition and practitioner protocol.
  • After injection, lightly massage the treated area if needed to distribute the product evenly and reduce the risk of palpable lumps.
  • Advise patients to avoid makeup for several hours post-treatment and to avoid saunas, intense exercise, alcohol and excessive heat or sun exposure for 24–48 hours.
  • Instruct on the use of broad-spectrum sunscreen and gentle skincare to maintain results and minimise risk of post-treatment pigmentation or irritation.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid or any component of the product.
  • Presence of active skin infections, inflammation or lesions (e.g. herpes, dermatitis, severe acne) at or near the intended injection site.
  • Autoimmune diseases or uncontrolled systemic disease where injectable aesthetic procedures are considered unsafe by the treating clinician.
  • History of severe allergic reactions or anaphylaxis to injectable products.
  • Pregnancy and breastfeeding, as safety has not been established and use is generally discouraged.
  • Tendency to keloid or hypertrophic scarring in the planned treatment area, unless carefully assessed and justified.
  • Recent aggressive cosmetic procedures (deep chemical peels, ablative laser, dermabrasion) in the area without adequate healing time.
  • Use in patients under 18 years of age or outside approved age ranges where local regulations apply.

Adverse Effects

  • Common transient injection-site reactions such as redness, swelling, tenderness, itching, pain or bruising.
  • Temporary lumps or papules at injection points, usually resolving as the product integrates into the tissue.
  • Mild asymmetry or irregularity if product distribution is uneven, generally correctable with massage or subsequent adjustment.
  • Rare inflammatory reactions, including prolonged swelling or induration, which may require medical evaluation and treatment.
  • Very rare risk of infection at the injection site if aseptic technique or aftercare is inadequate.
  • As with all dermal fillers, there is a rare but serious risk of vascular occlusion if injected intravascularly; emergency protocols and hyaluronidase access are required in all clinics providing treatment.

Storage Conditions

  • Store according to manufacturer’s instructions, typically between 2°C and 25°C.
  • Protect from direct sunlight and excessive heat; do not freeze.
  • Keep the syringe in its original blister and outer carton until use to maintain sterility and traceability.
  • Do not use after the expiry date printed on the packaging.
  • Do not use if packaging, blister or syringe is damaged or shows signs of compromised sterility.

Duration

Results from a course of Hyamira 32mg typically last several months; many distributors report durability in the range of 4\u20136 months or more, depending on patient age, skin quality, lifestyle and maintenance treatment schedule.

Onset

Hydration and improved turgidity are often noticeable shortly after treatment, with further improvements in texture, tone and fine lines becoming more apparent over the following days to weeks as dermal rehydration and bio-revitalisation progress.

Browse more Injectable dermal filler / skin booster

Top Treatments

Top Cities in the UK